- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03806647
Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 1)
January 16, 2019 updated by: Taipei Veterans General Hospital, Taiwan
Taipei Veterans General Hospital
The research is aimed to explore the needs of clinical patients and their caregiver,so as to provide suggestions to the designer of the communication system.
Study Overview
Status
Unknown
Conditions
Detailed Description
To promote and develop a smart communication system is helpful to patients with amyotrophic lateral sclerosis (ALS),especially for stage 3 and stage 4 (late stage).
Through the needs assessment, the research is aimed to explore the needs of clinical patients and their caregiver,so as to provide suggestions to the designer of the communication system.
Study Type
Observational
Enrollment (Anticipated)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
TW
-
Taipei, TW, Taiwan, 11217
- Recruiting
- Taipei Veterans General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Participants with ALS were recruited from ALS clinics(Taipei Veterans General Hospital, Taiwan, R.O.C),20 participants.
Participants were eligible for this study if they were diagnosed with definite, probable, probable laboratory-supported, or possible ALS according to the criteria (Brooks et al., 2000).
Description
Inclusion Criteria:
- Clinical diagnosis of ALS
- Taiwanese and used traditional Chinese(Mandarin).
- If they were older than age 20 years.
Exclusion Criteria:
- Frontotemporal dementia, severe depression, or schizophrenia.
- If they cannot complete the questionnaire with researchers or family members help.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Amyotrophic Lateral Sclerosis Supportive Care Needs (ALSSCN)
Time Frame: 2018.10.01~2020.04.31
|
The ALSSCN consisted of 37 items with seven domains: physical, psychological, emotional, spiritual, social, informational, and practical needs.
|
2018.10.01~2020.04.31
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2018
Primary Completion (ANTICIPATED)
April 1, 2020
Study Completion (ANTICIPATED)
September 1, 2020
Study Registration Dates
First Submitted
January 14, 2019
First Submitted That Met QC Criteria
January 14, 2019
First Posted (ACTUAL)
January 16, 2019
Study Record Updates
Last Update Posted (ACTUAL)
January 18, 2019
Last Update Submitted That Met QC Criteria
January 16, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-09-001A-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Amyotrophic Lateral Sclerosis
-
Ruijin HospitalActive, not recruitingALS (Amyotrophic Lateral Sclerosis) | ALS - Amyotrophic Lateral SclerosisChina
-
ZIWIGMonitoring Force GroupActive, not recruitingAmyotrophic Lateral Sclerosis | Amyotrophic Lateral Sclerosis, SporadicFrance
-
Washington University School of MedicineMassachusetts General HospitalSuspendedAmyotrophic Lateral Sclerosis, Familial | Amyotrophic Lateral Sclerosis, SporadicUnited States
-
Synchron, Inc.RecruitingALS (Amyotrophic Lateral Sclerosis) | Motor Neuron Disease | ALS | Neurological Disorder | ALS - Amyotrophic Lateral SclerosisUnited States
-
National Institute of Neurological Disorders and...RecruitingAmyotrophic Lateral Sclerosis Type 4 | Inherited Neurological Disorders of RNA ProcessingUnited States
-
Massachusetts General HospitalNot yet recruitingALS (Amyotrophic Lateral Sclerosis) | ALS | ALS - Amyotrophic Lateral Sclerosis
-
Biocells MedicalActive, not recruitingAmyotrophic Lateral Sclerosis (ALS) | Amyotrophic Lateral Sclerosis &Amp; Other Neuromuscular DisordersPoland
-
Groupe Hospitalier du HavreFrench Physiotherapy Society / Société Français de PhysiothérapieRecruitingAmyotrophic Lateral Sclerosis ALS7France
-
Nova Southeastern UniversityRecruitingAmyotrophic Lateral Sclerosis (ALS) | Motor Neuron Disease, Amyotrophic Lateral Sclerosis | Primary Lateral Sclerosis (PLS)United States
-
Tanabe Pharma CorporationCompletedAmyotrophic Lateral Sclerosis (ALS)